Small Molecule Target Identification
Small Molecule Target Identification - Related Videos
09:26
Isolation of Specific Genomic Regions and Identification of Associated Molecules by enChIP
0 Views •
Cited by 4 •
2016
The identification of molecules associated with specific genomic regions of interest is required to understand the mechanisms of regulation of the functions of these regions. This protocol describes procedures to perform engineered DNA-binding molecule-mediated chromatin imunoprecipitation (enChIP) for identification of proteins and RNAs associated with a specific genomic region.
01:29
Pharmacogenomics: Identification of New Drug Targets
0 Views •
2026
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
10:49
Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
0 Views •
Cited by 4 •
2016
We describe here a method for identification of small molecule-binding proteins using photoaffinity labeling. The advantage of this technique is that binding and covalent labeling of the target proteins occurs within the live cellular environment, removing the risk of disrupting native protein structure and binding conditions upon cell lysis.
08:34
A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
0 Views •
Cited by 6 •
2015
A protocol for small molecular drug screening based on in-situ synthesis of ultrasmall fluorescent gold nanoclusters (Au NCs) using drug-loaded protein as template is presented. This method is simple to determine the binding affinity of drugs to a target protein by a visible fluorescent signal emitted from the protein-templated Au NCs.
10:21
Protein Target Prediction and Validation of Small Molecule Compound
0 Views •
2024
The experiment used here shows a method of molecular docking combined with cellular thermal shift assay to predict and validate the interaction between small molecules and protein targets.
FAQs
Binding measurements indicate physical association, biochemical function tests show whether that interaction alters molecular activity, and cellular responses reveal effects in intact systems. Genetic or chemical perturbation then tests whether changing a candidate target changes the phenotype. Agreement across these levels strengthens mechanistic assignment, whereas a single assay may show activity without identifying the responsible biomolecule.
A compound can produce a desired biological effect through one target while affecting other biomolecules that contribute to toxicity or unrelated responses. Comparing target engagement, biochemical activity, cellular changes, and perturbation results helps separate these possibilities. This distinction clarifies mechanism of action and gives lead optimization a basis for improving selectivity rather than simply increasing overall activity.
Target validation asks whether the proposed biomolecule is necessary or sufficiently linked to the observed response. Researchers examine whether genetic or chemical perturbation changes the compound-associated phenotype and compare those results with binding and functional measurements. Consistent evidence reduces the risk of assigning activity to a correlated pathway or molecule rather than the causative target.
The workflow begins with a measurable compound activity or phenotype, followed by candidate-target investigation using binding and biochemical function measurements. Researchers then examine cellular responses and perturb candidate targets genetically or chemically. Final validation integrates these results to connect the compound with a specific biomolecule or pathway and to assess whether the proposed mechanism explains the observed effect.
Evidence may come from direct interaction with proteins or nucleic acids, changes in biochemical function, altered cellular responses, or effects produced when candidate targets are genetically or chemically perturbed. These evidence types answer different questions: whether association occurs, whether molecular activity changes, whether cells respond, and whether the candidate is mechanistically connected to the phenotype.
In drug discovery, target information helps explain mechanism of action, identify off-target toxicity, and guide lead optimization. In chemical biology, it connects compounds with biological processes and helps investigate signaling or metabolic pathways. The same evidence can therefore support therapeutic development while also improving understanding of how molecular perturbations influence cellular systems.